Corcept Therapeutics Incorporated - Common Stock (NQ:CORT)

122.97 +1.92 (+1.59%)

Streaming Delayed Price Updated: 10:38 AM EDT, Aug 21, 2026 Add to My Watchlist

Price and Volume

Volume	86,706
Open	121.48
Bid (Size)	122.86 (100)
Ask (Size)	123.10 (100)
Prev. Close	121.05
Today's Range	121.13 - 123.44
52wk Range	28.66 - 122.21
Shares Outstanding	115,926,629
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Mid-Cap Stock for Long-Term Investors and 2 That Underwhelm

Today 0:34 EDT

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...

Via StockStory

Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)

August 19, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Corcept (NASDAQ:CORT) and its...

Via StockStory

Performance

YTD	+221.9%	+221.9%
1 Month	+28.6%	+28.6%
3 Month	+106.0%	+106.0%
6 Month	+259.1%	+259.1%
1 Year	+74.7%	+74.7%

More News

1 Surging Stock to Own for Decades and 2 We Brush Off

August 13, 2026

Via StockStory

3 Cash-Producing Stocks We Steer Clear Of

August 04, 2026

Via StockStory

Corcept Therapeutics (NASDAQ:CORT) Surges 21% After Q2 Earnings Beat and Raised Guidance ↗

July 29, 2026

Via Chartmill

Corcept Therapeutics Inc (NASDAQ:CORT) Shows Strong Growth Fundamentals and Technical Breakout Setup ↗

July 11, 2026

Via Chartmill

Corcept Therapeutics Q2 Earnings Call Highlights ↗

July 29, 2026

Via MarketBeat

Curious about the stocks that are showing activity after the closing bell on Wednesday? ↗

July 29, 2026

Via Chartmill

Corcept (NASDAQ:CORT) Reports Bullish Q2 CY2026, Stock Jumps 17.4%

July 29, 2026

Via StockStory

Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update

July 29, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

Corcept (CORT) Q2 Earnings: What To Expect

July 27, 2026

Via StockStory

Why Corcept (CORT) Stock Is Down Today

July 27, 2026

Via StockStory

Spotting Winners: Corcept (NASDAQ:CORT) And Branded Pharmaceuticals Stocks In Q1

July 26, 2026

Via StockStory

Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call

July 22, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know ↗

July 20, 2026

Via The Motley Fool

A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound ↗

July 20, 2026

Via The Motley Fool

Corcept Insider Sells Shares After an FDA Approval and a $1.05 Billion Outlook ↗

July 12, 2026

Via The Motley Fool

3 Cash-Heavy Stocks with Questionable Fundamentals

July 07, 2026

Via StockStory

3 High-Flying Stocks We Steer Clear Of

June 30, 2026

Via StockStory

3 Unpopular Stocks We Steer Clear Of

June 23, 2026

Via StockStory

Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

June 17, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym®

June 06, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Question

June 01, 2026

Via StockStory

Corcept Presents New Data at ASCO 2026: Lifyorli™ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure

May 29, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

May 27, 2026

From Corcept Therapeutics Incorporated

Via Business Wire

Frequently Asked Questions

Is Corcept Therapeutics Incorporated - Common Stock publicly traded?

Yes, Corcept Therapeutics Incorporated - Common Stock is publicly traded.

What exchange does Corcept Therapeutics Incorporated - Common Stock trade on?

Corcept Therapeutics Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Corcept Therapeutics Incorporated - Common Stock?

The ticker symbol for Corcept Therapeutics Incorporated - Common Stock is CORT on the Nasdaq Stock Market

What is the current price of Corcept Therapeutics Incorporated - Common Stock?

The current price of Corcept Therapeutics Incorporated - Common Stock is 122.97

When was Corcept Therapeutics Incorporated - Common Stock last traded?

The last trade of Corcept Therapeutics Incorporated - Common Stock was at 08/21/26 10:38 AM ET

What is the market capitalization of Corcept Therapeutics Incorporated - Common Stock?

The market capitalization of Corcept Therapeutics Incorporated - Common Stock is 14.26B

How many shares of Corcept Therapeutics Incorporated - Common Stock are outstanding?

Corcept Therapeutics Incorporated - Common Stock has 14B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.